The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
The low-risk papillomaviruses
Open accessAbstract
Human Papillomavirus (HPV) research has been dominated by the study of a subset of Alpha papillomaviruses that together cause almost 5% of human cancers worldwide, with the focus being on the two most prominent of these (HPV16 and 18). These viruses are referred to as 'high-risk' (hrHPV), to distinguish them from the over 200 prevalent HPV types that more commonly cause only benign epithelial lesions. The 'low-risk' (lrHPV) term used to describe this group belies their cumulative morbidity. Persistent laryngeal papillomas, which occur rarely in children and adults, require regular surgical de-bulking to allow breathing. Such infections are not curable, and despite being caused by HPV11 (a lrHPV) are associated with 1-3% risk of cancer progression if not resolved. Similarly, the ubiquitous Beta HPV types, which commonly cause asymptomatic infections at cutaneous sites, can sometimes cause debilitating papillomatosis with associated cancer risk. Recalcitrant genital warts, which affect 1 in 200 young adults in the general population, and even the ubiquitous common warts and verrucas that most of us at some time experience, cannot be reliably eradicated, with treatment strategies advancing little over the last 100 years. The review highlights molecular similarities between high and low-risk HPV types, and focuses on the different pathways that the two groups use to ensure persistent infection and adequate virus shedding from the epithelial surface. Understanding the normal patterns of viral gene expression that underlie lesion formation, and which also prevent loss of the infected basal cells in established lesions, are particularly important when considering new treatment options. Finally, the common requirement for deregulated viral gene expression and genome persistence in development of cancers, unites both high and low-risk HPV types, and when considered alongside viral protein functions, provides us with a working understanding of the mechanisms that underlie HPV-associated pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Jackson, S., & Storey, A. (2000) · Oncogene · doi:10.1038/sj.onc.1203339 · Cited by 190
RetractedClassification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
Bernard, H.-U., Burk, R. D., Chen, Z., van Doorslaer, K., Hausen, H. Z., & de Villiers, E.-M. (2010) · Virology · doi:10.1016/j.virol.2010.02.002 · Cited by 1,669
Papillomaviruses in the causation of human cancers - a brief historical account
zur Hausen, H. (2009) · Virology · doi:10.1016/j.virol.2008.11.046 · Cited by 1,532
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
Self-citationLi, N., Franceschi, S., Howell‐Jones, R., Snijders, P. J. F., & Clifford, G. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.25396 · Cited by 1,066
Human papillomavirus molecular biology and disease association
Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., & Murakami, I. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1822 · Cited by 941
Self-citationDrolet, M., Bénard, É., Boily, M.-C., Ali, H., Baandrup, L., Bauer, H., Beddows, S., Brisson, J., Brotherton, J. M. L., Cummings, T., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71073-4 · Cited by 642
Immune responses to human papillomavirus
Stanley, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.002 · Cited by 586
Geha, R. S., Notarangelo, L. D., Casanova, J.-L., Chapel, H., Conley, M. E., Fischer, A., Hammarström, L., Nonoyama, S., Ochs, H. D., Puck, J. M., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.053 · Cited by 557
Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia
Egawa, N., Egawa, K., Griffin, H., & Doorbar, J. (2015) · Viruses · doi:10.3390/v7072802 · Cited by 553
Self-citationEpithelial Cell Responses to Infection with Human Papillomavirus
Stanley, M. A. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05028-11 · Cited by 473
Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis?
Pett, M., & Coleman, N. (2007) · The Journal of Pathology · doi:10.1002/path.2192 · Cited by 451
Herfs, M., Yamamoto, Y., Laury, A., Wang, X., Nucci, M. R., McLaughlin-Drubin, M. E., Münger, K., Feldman, S., McKeon, F. D., Xian, W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202684109 · Cited by 437
The papillomavirus E7 proteins
Roman, A., & Munger, K. (2013) · Virology · doi:10.1016/j.virol.2013.04.013 · Cited by 409
Jiang, M., & Milner, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205878 · Cited by 369
Duensing, S., & Münger, K. (2004) · International Journal of Cancer · doi:10.1002/ijc.11691 · Cited by 366
Papillomavirus E6 oncoproteins
Vande Pol, S. B., & Klingelhutz, A. J. (2013) · Virology · doi:10.1016/j.virol.2013.04.026 · Cited by 346
Orth, G., Jablonska, S., Favre, M., Croissant, O., Jarzabek-Chorzelska, M., & Rzesa, G. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.3.1537 · Cited by 293
Butz, K., Ristriani, T., Hengstermann, A., Denk, C., Scheffner, M., & Hoppe-Seyler, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206894 · Cited by 283
The E4 protein; structure, function and patterns of expression
Doorbar, J. (2013) · Virology · doi:10.1016/j.virol.2013.07.008 · Cited by 276
Self-citationHummel, M., Hudson, J. B., & Laimins, L. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.6070-6080.1992 · Cited by 271
Properties of a non‐tumorigenic human cervical keratinocyte cell line
Stanley, M. A., Browne, H. M., Appleby, M., & Minson, A. C. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430422 · Cited by 267
Evolution of the Papillomaviridae
Van Doorslaer, K. (2013) · Virology · doi:10.1016/j.virol.2013.05.012 · Cited by 261
Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses
Orth, G. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.008 · Cited by 249
General Acquisition of Human Papillomavirus Infections of Skin Occurs in Early Infancy
Antonsson, A., Karanfilovska, S., Lindqvist, P. G., & Hansson, B. G. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2509-2514.2003 · Cited by 225
Flores, E. R., & Lambert, P. F. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7167-7179.1997 · Cited by 219
Stoler, M. H., Wolinsky, S. M., Whitbeck, A., Broker, T. R., & Chow, L. T. (1989) · Virology · doi:10.1016/0042-6822(89)90135-9 · Cited by 213
Pett, M. R., Alazawi, W. O. F., Roberts, I., Dowen, S., Smith, D. I., Stanley, M. A., & Coleman, N. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3214 · Cited by 204
Regulation of Notch1 Gene Expression by p53 in Epithelial Cells
Yugawa, T., Handa, K., Narisawa-Saito, M., Ohno, S.-I., Fujita, M., & Kiyono, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02119-06 · Cited by 199
Bravo, I. G., & Félez-Sánchez, M. (2015) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eov003 · Cited by 199
Primary immunodeficiency diseases: An update
Notarangelo, L., Casanova, J.-L., Fischer, A., Puck, J., Rosen, F., Seger, R., & Geha, R. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.044 · Cited by 194
Beta genus papillomaviruses and skin cancer
Howley, P. M., & Pfister, H. J. (2015) · Virology · doi:10.1016/j.virol.2015.02.004 · Cited by 193
Antonsson, A., Erfurt, C., Hazard, K., Holmgren, V., Simon, M., Kataoka, A., Hossain, S., Håkangård, C., & Hansson, B. G. (2003) · Journal of General Virology · doi:10.1099/vir.0.18836-0 · Cited by 190
Lazarczyk, M., Pons, C., Mendoza, J.-A., Cassonnet, P., Jacob, Y., & Favre, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071311 · Cited by 190
Forslund, O., Iftner, T., Andersson, K., Lindelöf, B., Hradil, E., Nordin, P., Stenquist, B., Kirnbauer, R., Dillner, J., de Villiers, E., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521031 · Cited by 184
Tsolakas, T. C., Jp, D., & Oram, S. H. (1965) · PubMed · Cited by 183
Human Papillomavirus Vaccines – Immune Responses
Stanley, M., Pinto, L. A., & Trimble, C. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.106 · Cited by 180
Lutzner, M., Orth, G., Dutronquay, V., Ducasse, M.-F., Kreis, H., & Crosnier, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90389-6 · Cited by 176
Maglennon, G. A., McIntosh, P., & Doorbar, J. (2011) · Virology · doi:10.1016/j.virol.2011.03.019 · Cited by 175
Self-citationLutzner, M. A., Blanchet‐Bardon, C., & Orth, G. (1984) · Journal of Investigative Dermatology · doi:10.1038/jid.1984.15 · Cited by 169
Bonagura, V. R., Hatam, L., Rosenthal, D. W., VOTI, J. A. D., Lam, F., Steinberg, B. M., & Abramson, A. L. (2010) · Apmis · doi:10.1111/j.1600-0463.2010.02617.x · Cited by 158
Underbrink, M. P., Howie, H. L., Bedard, K. M., Koop, J. I., & Galloway, D. A. (2008) · Journal of Virology · doi:10.1128/jvi.00902-08 · Cited by 158
Pett, M. R., Herdman, M. T., Palmer, R. D., Yeo, G. S. H., Shivji, M. K. K., Stanley, M., & Coleman, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600078103 · Cited by 157
Zhang, B., Chen, W., & Roman, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510012103 · Cited by 156
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy
Ganti, K., Broniarczyk, J. K., Manoubi, W., Massimi, P., Mittal, S., Pim, D., Szalmás, A., Thatte, J. V., Thomas, M., Tomaić, V., et al. (2015) · Viruses · doi:10.3390/v7072785 · Cited by 144
Brimer, N., Lyons, C., Wallberg, A. E., & Vande Pol, S. B. (2012) · Oncogene · doi:10.1038/onc.2011.589 · Cited by 133
Betapapillomaviruses frequently persist in the skin of healthy individuals
de Koning, M. N. C., Struijk, L., Bavinck, J. N. B., Kleter, B., ter Schegget, J., Quint, W. G. V., & Feltkamp, M. C. W. (2007) · Journal of General Virology · doi:10.1099/vir.0.82732-0 · Cited by 133
Tan, M. J. A., White, E. A., Sowa, M. E., Harper, J. W., Aster, J. C., & Howley, P. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205991109 · Cited by 132
Schmitt, A., Rochat, A., Zeltner, R., Borenstein, L. A., Barrandon, Y., Wettstein, F. O., & Iftner, T. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1912-1922.1996 · Cited by 131
Lazarczyk, M., Cassonnet, P., Pons, C., Jacob, Y., & Favre, M. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00033-08 · Cited by 131
Human Beta‐papillomavirus infection and keratinocyte carcinomas
Quint, K. D., Genders, R. E., de Koning, M. N., Borgogna, C., Gariglio, M., Bavinck, J. N. B., Doorbar, J., & Feltkamp, M. C. W. (2014) · The Journal of Pathology · doi:10.1002/path.4425 · Cited by 121
Self-citationEstimation of the impact of genital warts on health-related quality of life
Woodhall, S. C., Ramsey, T., Cai, C., Crouch, S., Jit, M., Birks, Y. F., Edmunds, W. J., Newton, R., & Lacey, C. J. (2008) · Sexually Transmitted Infections · doi:10.1136/sti.2007.029512 · Cited by 121
Woodhall, S. C., Jit, M., Soldan, K., Kinghorn, G. R., Gilson, R. J. C., Nathan, M., Ross, J. D. C., & Lacey, C. J. (2011) · Sexually Transmitted Infections · doi:10.1136/sextrans-2011-050073 · Cited by 116
Guimerà, N., Lloveras, B., Lindeman, J., Alemany, L., van de Sandt, M. M., Alejo, M., Hernandez-Suarez, G. A., Bravo, I. G., Molijn, A. C., Jenkins, D., et al. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31828b6be4 · Cited by 110
Ruesch, M. N., Stubenrauch, F., & Laimins, L. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5016-5024.1998 · Cited by 110
Human keratinocytes have two interconvertible modes of proliferation
Roshan, A., Murai, K., Fowler, J. C., Simons, B. D., Nikolaidou-Neokosmidou, V., & Jones, P. H. (2015) · Nature Cell Biology · doi:10.1038/ncb3282 · Cited by 101
Xue, Y., Bellanger, S., Zhang, W., Lim, D. G. S., Low, J. J. H., Lunny, D. P., & Thierry, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3789 · Cited by 100
Cornall, A. M., Roberts, J. M., Garland, S. M., Hillman, R. J., Grulich, A. E., & Tabrizi, S. N. (2013) · International Journal of Cancer · doi:10.1002/ijc.28228 · Cited by 99
Muench, P., Probst, S., Schuetz, J., Leiprecht, N., Busch, M., Wesselborg, S., Stubenrauch, F., & Iftner, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1307 · Cited by 95
Herfs, M. F., Vargas, S. O., Yamamoto, Y., Howitt, B. E., Nucci, M. R., Hornick, J. L., McKeon, F., Xian, W., & Crum, C. P. (2012) · The Journal of Pathology · doi:10.1002/path.4110 · Cited by 93
Meyers, J. M., Spangle, J. M., & Münger, K. (2013) · Journal of Virology · doi:10.1128/jvi.02527-12 · Cited by 91
Different Modes of Human Papillomavirus DNA Replication during Maintenance
Hoffmann, R. T., Hirt, B., Bechtold, V. J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4431-4439.2006 · Cited by 90
Egawa, N., Nakahara, T., Ohno, S.-I., Narisawa‐Saito, M., Yugawa, T., Fujita, M., Yamato, K., Natori, Y., & Kiyono, T. (2012) · Journal of Virology · doi:10.1128/jvi.06450-11 · Cited by 86
Self-citationConnolly, K., Manders, P., Earls, P., & Epstein, R. J. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.08.005 · Cited by 79
Neveu, G., Cassonnet, P., Vidalain, P., Rolloy, C., Mendoza, J., Jones, L. M., Tangy, F., Muller, M., Demeret, C., Tafforeau, L., et al. (2012) · Methods · doi:10.1016/j.ymeth.2012.07.029 · Cited by 79
Fu, L., Doorslaer, K. V., Chen, Z., Ristriani, T., Masson, M., Travé, G., & Burk, R. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012816 · Cited by 73
Evans, M. F., Peng, Z., Clark, K. M., Adamson, C. S.-C., Ma, X., Wu, X., Wang, H., Luo, Y., & Cooper, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091142 · Cited by 72
Thomas, M., Myers, M. P., Massimi, P., Guarnaccia, C., & Banks, L. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005766 · Cited by 72
Do Human Papillomaviruses Target Epidermal Stem Cells?
Egawa, K. (2003) · Dermatology · doi:10.1159/000073085 · Cited by 68
Viral latency--the papillomavirus model.
Tr, B., Jin, G., Croom‐Rivers, A., Bragg, S. M., Richardson, M., Chow, L., Vermund, S. H., Alvarez, R. D., Pappas, P. G., Ke, S., et al. (2001) · PubMed · Cited by 67
Lazarczyk, M. J., Dalard, C., Hayder, M., Dupré, L., Pignolet, B., Majewski, S. T., Vuillier, F., Fãvre, M., & Liblau, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039995 · Cited by 64
de Koning, M. N. C., ter Schegget, J., Eekhof, J. A., Kamp, M., Kleter, B., Gussekloo, J., Feltkamp, M. C. W., Bavinck, J. N. B., Purdie, K. J., Bunker, C. B., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02122-09 · Cited by 63
Struijk, L., van der Meijden, E., Kazem, S., et al. (2008) · Journal of General Virology · doi:10.1099/vir.0.83317-0 · Cited by 58
Evolution of Human Papillomavirus Carcinogenicity
Doorslaer, K. V., & Burk, R. D. (2010) · Advances in virus research · doi:10.1016/b978-0-12-385034-8.00002-8 · Cited by 57
Cordano, P., Gillan, V., Bratlie, S., Bouvard, V., Banks, L., Tommasino, M., & Campo, M. S. (2008) · Virology · doi:10.1016/j.virol.2008.04.036 · Cited by 54
EPI-HPV-UV-CA group, Weißenborn, S. J., Neale, R. Ε., Waterboer, T., ABENI, D. D., Bavinck, J. N. B., Green, A. C., Harwood, C. A., Euvrard, S., Feltkamp, M. C. W., et al. (2011) · Medical Microbiology and Immunology · doi:10.1007/s00430-011-0212-3 · Cited by 53
Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen's disease
Zheng, S., Adachi, A., Shimizu, M., Shibata, S.-I., YASUE, S., Sakakibara, A., SUGIURA, M., Nagasaka, T., & Tomita, Y. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06643.x · Cited by 52
High-Risk Human Papillomavirus Targets Crossroads in Immune Signaling
Tummers, B., & van der Burg, S. (2015) · Viruses · doi:10.3390/v7052485 · Cited by 51
Spink, K. M., & Laimins, L. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4918-4926.2005 · Cited by 48
White, E. A., Walther, J., Javanbakht, H., & Howley, P. M. (2014) · Journal of Virology · doi:10.1128/jvi.01197-14 · Cited by 47
Low- and high-risk human papillomavirus E7 proteins regulate p130 differently
Barrow-Laing, L., Chen, W., & Roman, A. (2010) · Virology · doi:10.1016/j.virol.2010.01.034 · Cited by 39
Simmonds, M., & Storey, A. (2008) · International Journal of Cancer · doi:10.1002/ijc.23815 · Cited by 39
High-risk Human Papillomavirus E7 Oncoprotein Detection in Cervical Squamous Cell Carcinoma
Ressler, S., Scheiden, R., Dreier, K., Laich, A., Müller‐Holzner, E., Pircher, H., Morandell, D., Stein, I., Viertler, H., Santer, F. R., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1222 · Cited by 36
NUCLEIC ACID SYNTHESIS IN TYPES 4 AND 5 ADENOVIRUS-INFECTED H E L A CELLS
Ginsberg, H. S., & Dixon, M. K. (1961) · The Journal of Experimental Medicine · doi:10.1084/jem.113.2.283 · Cited by 28
Guimerà, N., Lloveras, B., Alemany, L., Iljazović, E., Shin, H., Jung‐Il, S., de Sanjosé, S., Jenkins, D., Bosch, F. X., & Quint, W. G. V. (2013) · Histopathology · doi:10.1111/his.12137 · Cited by 27
Anogenital Hairs Are an Important Reservoir of Alpha‐Papillomaviruses in Patients with Genital Warts
Poljak, M., Kocjan, B. J., Potočnik, M., & Seme, K. (2009) · The Journal of Infectious Diseases · doi:10.1086/597619 · Cited by 22
Regulation of the human papillomavirus type 16 late promoter by E7 and the cell cycle
Bodily, J. M., Hennigan, C., Wrobel, G. A., et al. (2013) · Virology · doi:10.1016/j.virol.2013.04.033 · Cited by 20
(1978) · PubMed
Cited by
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Pal, A., & Kundu, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03116 · Cited by 597
The natural history of human papillomavirus infection
de Sanjosé, S., Brotons, M., & Pavón, M. A. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.015 · Cited by 589
Human papillomavirus as a driver of head and neck cancers
Sabatini, M. E., & Chiocca, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0602-7 · Cited by 387
Human papillomaviruses: diversity, infection and host interactions
McBride, A. A. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00617-5 · Cited by 369
Yeo-Teh, N. S. L., Ito, Y., & Jha, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061706 · Cited by 273
Metadata
- Authors
- Egawa, N., & Doorbar, J.
- Venue
- Virus Research
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 231
- Pages
- 119-127
- ISSN
- 0168-1702 (ISSN-L)
- OpenAlex
- W2565448904
- Cited by
- 330
- References
- 89
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.